Scottish Cost Regulators Approves Alimta and Stelara for NHS Use
Submitted by Jason Ramsey on Tue, 02/09/2010 - 21:42
The Scottish Medicines Consortium has announced the approval for the use of Eli Lilly's Alimta for lung cancer and Janssen-Cilag's Stelara for psoriasis on the National Health Service.
Latest News
|
|
|
|
|
|
|
|
|
|
|
|
